Indivior (LON:INDV) Shares Down 15.7% – Should You Sell?

Shares of Indivior PLC (LON:INDV) fell 15.7% during trading on Thursday . The company traded as low as GBX 548.71 ($6.93) and last traded at GBX 732 ($9.25). 1,888,371 shares traded hands during mid-day trading, an increase of 166% from the average session volume of 709,477 shares. The stock had previously closed at GBX 868 ($10.97).

Wall Street Analysts Forecast Growth

Separately, Jefferies Financial Group reiterated a “buy” rating and issued a GBX 1,800 ($22.74) price target on shares of Indivior in a research note on Tuesday, December 17th.

Indivior Trading Down 5.9 %

The stock has a market cap of £1.08 billion, a price-to-earnings ratio of -570.87, a PEG ratio of -5.57 and a beta of 0.19. The company has a quick ratio of 1.52, a current ratio of 0.83 and a debt-to-equity ratio of -170.06. The business’s 50 day simple moving average is GBX 920.11 and its 200 day simple moving average is GBX 850.81.

Indivior Company Profile

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.